A. Board-member-for, M. Abbvie, . Takeda, . Pfizer, . Mundipharma et al., Consulting fees from Merck

A. Merck, . Takeda, . Janssen, . Takeda, . Ferring et al., HAC-pharma; SD has served as a speaker, consultant, and advisory board member for Schering-Plough

K. Thia, W. Sandborn, W. Harmsen, A. Zinsmeister, and E. Loftus, Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort, Gastroenterology, vol.139, pp.1147-55, 2010.

B. Pariente, J. Cosnes, S. Danese, W. Sandborn, M. Lewin et al., Inflamm Bowel Dis, vol.17, pp.1415-1437, 2011.

B. Pariente, J. Mary, S. Danese, Y. Chowers, D. Cruz et al.,

G. Tontini, A. Zagdanski, C. Bonifacio, J. Rimola, M. Nachury et al., Development of the Lemann index to assess digestive tract damage in patients with Crohn's disease, Gastroenterology, vol.148, p.3, 2015.

G. Fiorino, C. Bonifacio, M. Allocca, A. Repici, L. Balzarini et al., Bowel Damage as Assessed by the Lemann Index is Reversible on Anti-TNF Therapy for Crohn's Disease, J Crohns Colitis, vol.9, pp.633-642, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01667769

L. Peyrin-biroulet, V. Billioud, D. 'haens, G. Panaccione, R. Feagan et al.,

E. Louis, F. Steinwurz, W. Reinisch, P. Rutgeerts, J. Colombel et al., Development of the Paris definition of early Crohn's disease for diseasemodification trials: results of an international expert opinion process, Am J Gastroenterol, vol.107, pp.1770-1776, 2012.

S. Danese, G. Fiorino, C. Fernandes, and L. Peyrin-biroulet, Catching the therapeutic window of opportunity in early Crohn's disease, Curr Drug Targets, vol.15, pp.1056-63, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01687387

L. Peyrin-biroulet, E. Loftus, J. Colombel, J. Sandborn, and W. J. , Early Crohn disease: a proposed definition for use in disease-modification trials, Gut, vol.59, pp.141-148, 2010.

C. Gilletta, M. Lewin, A. Bourrier, I. Nion-larmurier, S. Rajca et al., Changes in the Lemann Index Values During the First Years of Crohn's Disease, Clin Gastroenterol Hepatol, vol.13, p.3, 2015.

E. Safroneeva, S. Vavricka, N. Fournier, V. Pittet, L. Peyrin-biroulet et al., Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease, Aliment Pharmacol Ther, vol.42, pp.977-89, 2015.

J. Rimola, S. Rodriguez, O. Garcia-bosch, I. Ordas, E. Ayala et al., Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease, Gut, vol.58, pp.1113-1133, 2009.

J. Rimola, I. Ordas, S. Rodriguez, O. Garcia-bosch, M. Aceituno et al., Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity, Inflamm Bowel Dis, vol.17, pp.1759-68, 2011.

A. Jauregui-amezaga, J. Rimola, I. Ordas, S. Rodriguez, A. Ramirez-morros et al., Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics, Gut, vol.64, pp.1397-402, 2015.

D. Collet, Modelling survival data in medical research, 1994.

P. Grambsch and T. Therneau, Proportional hazards tests and diagnostics based on weighted residuals, Biometrika, vol.81, pp.515-526, 1994.

G. Van-assche, A. Dignass, J. Panes, L. Beaugerie, J. Karagiannis et al., The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis, J Crohns Colitis, vol.4, pp.7-27, 2010.

G. Fiorino, C. Bonifacio, L. Peyrin-biroulet, and S. Danese, Preventing Collateral Damage in Crohn's Disease: The Lemann Index, J Crohns Colitis, vol.10, pp.495-500, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01665013

J. Cosnes, S. Cattan, A. Blain, L. Beaugerie, F. Carbonnel et al.,

, Long-term evolution of disease behavior of Crohn's disease, Inflamm Bowel Dis, vol.8, pp.244-50, 2002.

S. Ghosh and R. Mitchell, Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey, J Crohns Colitis, vol.1, pp.10-20, 2007.

S. Vavricka, S. Spigaglia, G. Rogler, V. Pittet, P. Michetti et al., Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease, Inflamm Bowel Dis, vol.18, pp.496-505, 2012.

A. Schoepfer, M. Dehlavi, N. Fournier, E. Safroneeva, A. Straumann et al., Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate, Am J Gastroenterol, vol.108, pp.1744-53, 2013.

S. Danese, G. Fiorino, J. Mary, P. Lakatos, D. 'haens et al.,

J. Colombel, Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative, J Crohns Colitis, vol.9, pp.601-607, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01668612

P. Deepak, J. Fletcher, J. Fidler, J. Barlow, S. Sheedy et al.,

W. Loftus, E. Hansel, S. Becker, B. Bruining, and D. , Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease, Am J Gastroenterol, 2016.